PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187956. A total of 3 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,000 | -96.6% | 4,000 | -95.4% | 0.00% | -100.0% |
| Q4 2019 | $442,000 | +59.0% | 86,800 | +57.8% | 0.00% | +50.0% |
| Q3 2019 | $278,000 | +348.4% | 55,000 | +450.0% | 0.00% | +100.0% |
| Q2 2019 | $62,000 | +21.6% | 10,000 | -9.1% | 0.00% | 0.0% |
| Q1 2019 | $51,000 | -84.2% | 11,000 | -85.7% | 0.00% | -66.7% |
| Q4 2018 | $323,000 | -50.5% | 76,900 | -26.1% | 0.00% | -40.0% |
| Q3 2018 | $653,000 | +70.9% | 104,100 | +119.2% | 0.01% | +66.7% |
| Q2 2018 | $382,000 | -45.3% | 47,500 | -49.2% | 0.00% | -57.1% |
| Q1 2018 | $698,000 | +59.4% | 93,500 | +27.0% | 0.01% | +133.3% |
| Q4 2017 | $438,000 | +39.5% | 73,600 | +72.4% | 0.00% | 0.0% |
| Q3 2017 | $314,000 | +86.9% | 42,700 | +72.9% | 0.00% | +50.0% |
| Q2 2017 | $168,000 | -67.8% | 24,700 | -55.3% | 0.00% | -66.7% |
| Q1 2017 | $521,000 | +266.9% | 55,200 | +236.6% | 0.01% | +500.0% |
| Q4 2016 | $142,000 | -72.7% | 16,400 | -80.1% | 0.00% | -83.3% |
| Q3 2016 | $521,000 | +492.0% | 82,300 | +295.7% | 0.01% | +500.0% |
| Q2 2016 | $88,000 | -67.5% | 20,800 | -66.6% | 0.00% | -75.0% |
| Q1 2016 | $271,000 | +48.1% | 62,200 | +108.7% | 0.00% | +100.0% |
| Q4 2015 | $183,000 | +3.4% | 29,800 | -3.9% | 0.00% | 0.0% |
| Q3 2015 | $177,000 | -49.6% | 31,000 | -34.2% | 0.00% | -60.0% |
| Q2 2015 | $351,000 | -6.9% | 47,100 | -25.4% | 0.01% | -16.7% |
| Q1 2015 | $377,000 | +550.0% | 63,100 | +719.5% | 0.01% | +500.0% |
| Q4 2014 | $58,000 | +383.3% | 7,700 | +220.8% | 0.00% | – |
| Q3 2014 | $12,000 | -42.9% | 2,400 | -50.0% | 0.00% | – |
| Q2 2014 | $21,000 | -84.1% | 4,800 | -85.1% | 0.00% | -100.0% |
| Q1 2014 | $132,000 | -25.0% | 32,200 | -2.4% | 0.00% | -33.3% |
| Q4 2013 | $176,000 | -3.3% | 33,000 | -8.6% | 0.00% | 0.0% |
| Q3 2013 | $182,000 | -21.9% | 36,100 | -31.0% | 0.00% | -50.0% |
| Q2 2013 | $233,000 | – | 52,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 31,000 | $177,000 | 0.00% |
| Citadel Advisors | 12,800 | $73,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1 | $0 | 0.00% |